Premium
Torsades de Pointes and QT Prolongation Due to a Combination of Loratadine and Amiodarone
Author(s) -
ATAR SHAUL,
FREEDBERG NAHUM A.,
ANTONELLI DANTE,
ROSENFELD TIBERIO
Publication year - 2003
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1046/j.1460-9592.2003.00137.x
Subject(s) - loratadine , torsades de pointes , medicine , amiodarone , qt interval , cardiology , mexiletine , anesthesia , long qt syndrome , terfenadine , quinidine , atrial fibrillation
ATAR, S., et al.: Torsades de Pointes and QT Prolongation Due to a Combination of Loratadine and Amiodarone.Torsades de pointes (TdP) has not been previously reported with loratadine. A 73‐year old woman on chronic treatment with amiodarone for atrial fibrillation received loratadine and presented with syncope and multiple episodes of TdP. We suggest that QT interval should be monitored whenever loratadine is co‐administered with drugs that may potentially prolong QT. (PACE 2003; 26:785–786)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom